In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

J&J plans to divest LifeScan unit to Platinum Equity for $2.1bn

Executive Summary

Private investment firm Platinum Equity launched a binding offer to acquire Johnson & Johnson's blood glucose monitoring unit LifeScan Inc. for $2.1bn. J&J has until June 15, 2018 to accept the offer and if it does, the transaction is expected to close by year end.
Deal Industry
  • In Vitro Diagnostics
    • Glucose Testing
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Buy-out

Related Companies

Advertisement
UsernamePublicRestriction

Register